key: cord-0069192-ijauuffc
authors: Case, Brian; Abramowitz, Jonathan; Shea, Corey; Rappaport, Hank; Medranda, Giorgio; Yerasi, Charan; Chezar-Azerrad, Chava; Zhang, Cheng; Satler, Lowell; Ben-Dor, Itsik; Hashim, Hayder; Rogers, Toby; Weintraub, William; Waksman, Ron
title: TCT-65 Characteristics of COVID-19 Patients With Thrombosis and Impact on Clinical Outcomes
date: 2021-11-09
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2021.09.915
sha: 7731ab14bf18b9da05a9ff973ae2a9fa94a44acb
doc_id: 69192
cord_uid: ijauuffc

nan

BACKGROUND Although in-hospital mortality for COVID-confirmed (COVIDþ) patients presenting with ST-elevated myocardial infarction (STEMI) is high, its predisposing risk factorsdand, in particular, the cumulative risk rendered by their combinationdis unknown. We sought to develop a risk score of in-hospital mortality in COVIDþ patients presenting with STEMI.

METHODS Baseline clinical and procedural characteristics of COVIDþ patients presenting with STEMI in the North American COVID-19 Myocardial Infarction (NACMI) registry were evaluated as univariable predictors of in-hospital mortality. A backwards, stepwise, logistic regression was used to create a multivariable model to identify independent predictors of in-hospital mortality with an inclusion P value < 0.1. Based on the model, 7 identified variables (age > 55, shock prepercutaneous coronary intervention, diabetes, mechanical ventilation, dyspnea on presentation, infiltrates on chest x-ray, and cardiopulmonary mechanical support) were assigned a weighted integer; the sum of the integers was a total risk score of in-hospital morality for each patient.

The overall occurrence of in-hospital mortality in 370 COVID-19þ cases presenting with STEMI was 28%. In-hospital mortality increased exponentially with increasing risk score (Cochran Armitage chi-square, P < 0.001), and the model demonstrated good discriminative power (C-statistic ¼ 0.85). The increasing risk score was strongly associated with in-hospital mortality (range < 1% to 65% for a low-and very high-risk score, respectively; see Figure 1 ).

CONCLUSION The risk of in-hospital mortality in COVIDþ patients presenting with STEMI can be simply assessed using readily available information. BACKGROUND Multiple studies have shown a significantly increased incidence of stress-induced cardiomyopathy (SICM) during the COVID-19 pandemic, likely owing to the psychosocial, economic, and physical stressors imposed on people's lives. Our aim is to study the incidence of SICM and its anatomic variants during the COVID-19 pandemic and to evaluate the impact of demographic, social, and economic factors.

METHODS We performed a retrospective analysis of patients admitted to the 3 Mayo Clinic centers (Minnesota, Arizona, Florida) between January 1, 2020, and December 31, 2020. Patients with SICM were identified using the ICD-10 code I51.81. All patients with SICM were divided into COVID-19-positive and COVID-19-negative groups for comparison. Patients who were not tested were excluded.

A total of 197 patients (mean age 67.4 AE 15.1 years, 72.6% female, 9.1% COVID-19 positive) were diagnosed with SICM during the 1-year study period. Overall, patients with SICM had median lengths of stay (LOS) of 6 days, in-hospital mortality rate of 12.2%, and a 30day readmission rate of 22.8%. A lower proportion of Whites (77.8% vs 99.2%) and Hispanics (0.0% vs 2.2%) and a higher proportion of Blacks (5.6% vs 3.9%), Asians (5.6% vs 1.1%), and American Indians (5.6% vs 0.0%) with SICM were COVID-19 positive, and this racial difference was statistically significant (P ¼ 0.02). Interestingly, the mortality rate was lower (11.1% vs 10.6%, P ¼ 0.05) in patients with SICM and COVID-19. The 2 groups were not significantly different for marital status, insurance type, anatomic variants, left ventricular ejection fraction, and 30-day readmission rates. CONCLUSION SICM usually occurs in the 6th to 7th decade of life and has a higher incidence in women. Racial minorities with SICM were disproportionately affcted during the pandemic with a higher incidence of COVID-19. However, in-hospital mortality rates were lower in COVID-19-positive patients with SICM.

left main (LM) coronary revascularization activity, choice of strategy, and post-procedural outcomes

Logistic regression models were performed to examine odds ratio (OR) of receipt of CABG (vs percutaneous coronary intervention [PCI]) and in-hospital and 30-day postprocedural

consistent across all age groups. No difference in adjusted in-hospital or 30-day mortality was observed between pre-COVID and COVID periods for both PCI

CONCLUSION LM revascularization activity has significantly declined during the COVID period, with a shift toward PCI as the preferred strategy. Post-procedural mortality within each revascularization group was similar in the pre-COVID and COVID periods, reflecting maintenance in quality of outcomes during the pandemic

Cost-Effectiveness, and Public Health Issues TCT-67

Mechanical Circulatory Support in Patients With COVID-19

Presenting With Myocardial Infarction: Analysis From the North American COVID-19 Myocardial Infarction Registry Raviteja Guddeti

Minneapolis Heart Institute Foundation

BACKGROUND ST-segment elevation myocardial infarction (STEMI) complicating COVID-19 infection is associated with increased risk of mortality and stroke. However, little is known about the use of mechanical circulatory support (MCS) among these patients

OBJECTIVES This article aims to define the patient characteristics and outcomes among COVID-19 patients with STEMI needing mechanical circulatory support

patients with STEMI requiring MCS were compared with those who did not receive MCS. Baseline patient characteristics and in-hospital outcomes were compared between the 2 groups. Primary outcome of interest was a composite of in-hospital mortality, stroke, recurrent MI, and repeat unplanned revascularization

RESULTS A total of 377 patients from the North American Covid-19

Myocardial Infarction (NACMI) registry were included in this analysis

COVIDþ/MCSþ vs 326 COVIDþ/MCS-). Men constituted 70.3% of all patients (75% in COVIDþ/MCSþ vs 70% in COVIDþ/MCS-). COVIDþ/MCSþ patients were more likely to be Caucasians compared with COVIDþ/MCS-patients

Forty-four percent of patients in the COVIDþ/MCSþ group presented with shock versus 10% in the COV-IDþ/MCS-group (P <0.001). Mean ejection fraction was significantly